Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of tocilizumab in adults with Erdheim-Chester disease
2012-003151-11Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in Erdheim-Chester disease (ECD), sponsored by IRCCS Ospedale San Raffaele. Started Sep 2012; status: completed.
02
Drugs
tocilizumab
03
Conditions
Erdheim-Chester disease (ECD)
Beyond the preview
Go deeper on 2012-003151-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003151-11.